What is the Market Size of Glp-1 in India | Insights, Trends & Growth Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10675

Publication Date: Nov 2025

What is the growth rate of the India GLP-1 Market?

According to 6Wresearch internal database and industry insights, India GLP-1 Market is expanding at a CAGR of 14.7% during the forecast period 2025-2031.

There are numbers of factors which are contributing in the expansion of the market include including rising cases of diabetes and obesity, increasing preference for weight-management therapies, innovation in injectable and oral GLP-1 drugs, supportive healthcare reimbursement initiatives, and higher awareness toward advanced antidiabetic treatment.

Key Growth Drivers of the India GLP-1 Market

Increasing rates of diabetes and obesity in urban and semi-urban areas
More people are using GLP-1 agonists to help them lose weight.
The introduction of new oral and long-acting injectable formulations
Increasing spending on healthcare and investments from the private sector
Physicians are increasingly favoring GLP-1 as it helps control blood sugar levels and helps people lose weight.

India GLP-1 Market Trends

India GLP-1 Market is witnessing higher usage of once-weekly injectable formulations that improve patient compliance. The popularity of oral GLP-1 therapies is increasing, especially among new patients seeking convenience over injections. Pharmaceutical firms are introducing combination therapies that integrate GLP-1 with insulin for improved clinical outcomes. Telemedicine adoption is encouraging faster diagnosis and early prescription of advanced antidiabetic drugs.

Awareness programs run by private hospitals and medical associations are further driving adoption. The growing popularity of weight loss programs that focus on lifestyle changes is driving up prescription rates.

Emerging Developments in the India GLP-1 Market

India GLP-1 Market is evolving with the introduction of next-generation oral formulations that target both weight and glucose management. Several companies are investing in R&D for dual and triple agonists that show stronger metabolic benefits. Licensing partnerships between drug companies are making it possible to quickly launch high-quality GLP-1 molecules in the US market. Clinical studies are still going on to find more ways to use GLP-1 to help with heart disease and metabolic disorders.

The growing interest in obesity management therapy from wellness clinics is making the product more visible. To cut down on reliance on imports, local manufacturing facilities are being expanded. Insurance companies are slowly adding advanced GLP-1 drugs to their coverage plans, which makes them easier to get.